Preoperative radiotherapy: A paradigm shift in the treatment of breast cancer? A review of literature.


Journal

Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 07 02 2019
revised: 12 05 2019
accepted: 03 06 2019
pubmed: 5 7 2019
medline: 18 10 2019
entrez: 5 7 2019
Statut: ppublish

Résumé

The standard of care for early-stage breast cancer (BC) consists of breast-conserving surgery followed by postoperative irradiation. Recently, the concept of changing the usual sequence of treatment components in BC RT has been investigated. Potential advantages of preoperative RT in BC include a possible tumor downstaging with improved surgical cosmetic outcomes, accurate tumor site identification and better target volume delineation. Furthermore, preoperative RT could serve as a tool for treatment stratification for de-escalation of treatments in the event of pathological complete response. The present literature review analyzed the available clinical data regarding the potential impact of preoperative RT. Overall, available clinical evidence of preoperative RT in BC remains limited, deriving mostly from retrospective case series. Nevertheless, the experiences prove the feasibility of the preoperative RT approach and confirm the efficacy in almost all analyzed studies, including experiences using higher prescription RT doses or RT in combination with systemic therapy.

Identifiants

pubmed: 31272045
pii: S1040-8428(19)30111-8
doi: 10.1016/j.critrevonc.2019.06.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102-111

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Stefanie Corradini (S)

Department of Radiation Oncology, University Hospital, University of Munich, Munich, Germany. Electronic address: stefanie.corradini@med.uni-muenchen.de.

David Krug (D)

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.

Icro Meattini (I)

Department of Biomedical, Experimental, and Clinical Sciences, University of Florence, Florence, Italy; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Christiane Matuschek (C)

Department of Radiotherapy and Radiation Oncology, Heinrich Heine University, Medical faculty, Düsseldorf, Germany.

Edwin Bölke (E)

Department of Radiotherapy and Radiation Oncology, Heinrich Heine University, Medical faculty, Düsseldorf, Germany.

Giulio Francolini (G)

Department of Biomedical, Experimental, and Clinical Sciences, University of Florence, Florence, Italy.

René Baumann (R)

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Kiel, Germany; Department of Radiation Oncology, St. Marien Hospital Siegen, Siegen, Germany.

Vanessa Figlia (V)

Department of Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria, Negrar di Valpolicella, Verona, Italy.

Montserrat Pazos (M)

Department of Radiation Oncology, University Hospital, University of Munich, Munich, Germany.

Fabrizio Tonetto (F)

Department of Radiation Oncology, Azienda Sanitaria Universitaria Integrata UD, Udine, Italy.

Marco Trovò (M)

Department of Radiation Oncology, Azienda Sanitaria Universitaria Integrata UD, Udine, Italy.

Rosario Mazzola (R)

Department of Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria, Negrar di Valpolicella, Verona, Italy.

Filippo Alongi (F)

Department of Advanced Radiation Oncology, IRCCS Sacro Cuore Don Calabria, Negrar di Valpolicella, Verona, Italy; University of Brescia, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH